Page last updated: 2024-08-17

tubocurarine and terfenadine

tubocurarine has been researched along with terfenadine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Galletly, DC; Robinson, BJ; Short, TG; Treuren, BC; Ure, RW1

Trials

1 trial(s) available for tubocurarine and terfenadine

ArticleYear
The influence of the H1 and H2 receptor antagonists, terfenadine and ranitidine on the hypotensive and gastric pH effects of the histamine releasing drugs, morphine and tubocurarine.
    Anaesthesia, 1993, Volume: 48, Issue:9

    Topics: Double-Blind Method; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Hypotension; Middle Aged; Morphine; Premedication; Ranitidine; Terfenadine; Tubocurarine

1993

Other Studies

1 other study(ies) available for tubocurarine and terfenadine

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013